These results suggested that ITGB6 overexpression may suppress the infiltration and anti‐tumour effect of CD8+ T cells in PC through Notch signalling pathway, suggesting ITGB6 as a therapeutic target of Notch signalling pathway. Here, CD8A is linked to neoplasm.